Keyphrases
Cisplatin-induced Hearing Loss
100%
Cisplatin-based Chemotherapy
100%
Hearing Protection
100%
Sirtuins
66%
Cisplatin
66%
Sirtuin 1 (SIRT1)
66%
Honokiol
66%
Sirtuin 3 (SIRT3)
50%
Antioxidant
50%
Protective Effect
50%
Sirtuin Family
33%
Reactive Oxygen Species
33%
Mitochondria
33%
Knock-in Mouse Model
16%
Intrinsic Networks
16%
Platinum Drugs
16%
Sirtuin 5 (SIRT5)
16%
Isocitrate Dehydrogenase 1 (IDH1)
16%
Deacetylase
16%
Tumor-bearing Mice Model
16%
Free Radical Scavenger
16%
Chemotherapy
16%
Intracellular Location
16%
Outer Hair Cell
16%
Antitumor Effect
16%
Detoxification
16%
Clinical Treatment
16%
Tumor Cells
16%
Hearing Impairment
16%
Cochlear Damage
16%
Anticancer Drugs
16%
Cancer Patients
16%
Chemotherapy Regimen
16%
Cancer Chemotherapy
16%
Oxidative Damage
16%
Multifunctional Compounds
16%
Reactive Oxygen Species Production
16%
Drug Use
16%
Toxic Effects
16%
Ototoxicity
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Cisplatin
100%
Hearing Impairment
63%
Sirtuin
54%
Honokiol
36%
Reactive Oxygen Metabolite
27%
Antioxidant
27%
Neoplasm
18%
Mouse Model
9%
Knockout Mouse
9%
Cancer Chemotherapy
9%
Malignant Neoplasm
9%
Ototoxicity
9%
Anticarcinogen
9%
Isocitrate Dehydrogenase 2
9%
Detoxication
9%
Nursing and Health Professions
Cisplatin
100%
Hearing Impairment
63%
Sirtuin
54%
Honokiol
36%
Antioxidant
27%
Reactive Oxygen Metabolite
27%
Neoplasm
18%
Detoxication
9%
Ototoxicity
9%
Malignant Neoplasm
9%
Cancer Chemotherapy
9%
Anticarcinogen
9%
Isocitrate Dehydrogenase 2
9%